MWM
AZN icon

Mosley Wealth Management’s AstraZeneca AZN Stock Holding History

Mosley Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9K Buy
+10
New +$1.88K ﹤0.01% 500

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mosley Wealth Management's AZN Position: Q2 2026 in Review

Mosley Wealth Management opened a new position in AstraZeneca (AZN) in Q2 2026: 10 shares worth $1.9K. The stake represents ﹤0.01% of the portfolio and ranks #500 among its holdings.

906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Mosley Wealth Management held 10 shares of AstraZeneca worth $1.9K as of Q2 2026.
  • AstraZeneca was a new Mosley Wealth Management position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Mosley Wealth Management's portfolio in Q2 2026, its #500 holding.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.